Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal®) to Provide Symptomatic Relief of Osteoarthritis of the Knee
Conditions
Interventions
Cingal
Triamcinolone Hexacetonide (TH)
+1 more
Locations
26
United States
Orthopaedic Specialist of North America, PLLC DBA OrthoArizona
Chandler, Arizona, United States
Valley Bone and Joint Specialists
Chandler, Arizona, United States
Tucson Orthopaedic Institute
Tucson, Arizona, United States
Advanced Research Center, Inc.
Anaheim, California, United States
Medvin Clinical Research
Covina, California, United States
Core Orthopaedic Medical Center (San Dieguito Orthopedic Medical Center)
Encinitas, California, United States
Start Date
September 11, 2020
Primary Completion Date
May 16, 2022
Completion Date
May 16, 2022
Last Updated
August 9, 2023
NCT07364578
NCT06488144
NCT07058623
NCT06083480
NCT06955481
NCT06208631
Lead Sponsor
Anika Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions